Elutia Quote - ELUT

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Current Price

3.45

Bid

3.00

Offer

4.80

Volume

44,290

3.28 Day's Range 3.60

2.28 52 Week Range 5.24

Market Cap

119.239M

Previous Close

3.40

Open

3.47

Last Trade

2.83

Last Trade Time

Financial Volume

US$ 151,826

VWAP

3.428

Average Volume (3m)

41,320

Shares Outstanding

34,562,098

Dividend Yield

PE Ratio

-3.12

Earnings Per Share (EPS)

-1.09

Revenue

24.75M

Net Profit

-37.66M

Aziyo Biologics Inc is a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, concentrating on patients receiving implantable medical devices. The products of the company are targeted ... Aziyo Biologics Inc is a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, concentrating on patients receiving implantable medical devices. The products of the company are targeted to address unmet clinical needs with the goal of promoting healthy tissue formation and avoiding complications associated with medical device implants, such as scar-tissue formation, capsular contraction, erosion, migration, non-union of implants and implant rejection. Show more

Sector

Biological Pds,ex Diagnstics

Industry

Biological Pds,ex Diagnstics

Website

www.elutia.com

Headquarters

Wilmington, Delaware, USA

Founded

Elutia Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker ELUT. The last closing price for Elutia was US$3.40. Over the last year, Elutia shares have traded in a share price range of US$ 2.28 to US$ 5.24.

Elutia currently has 34,562,098 shares in issue. The market capitalisation of Elutia is US$117.51 million. Elutia has a price to earnings ratio (PE ratio) of -3.12.

Elutia Awarded Cardiac Rhythm Management Devices Agreement with Premier, Inc.

SILVER SPRING, Md., Dec. 02, 2024 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia” or the “Company”), a pioneer in drug-eluting biomatrix products, announced it has been awarded a...

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Elutia Announces Strong Third Quarter Results, Accelerating Toward Full Launch of EluPro® Antibiotic-Eluting BioEnvelope in 2025

Over 100 EluPro VAC Submissions and 19% SimpliDerm Growth Drive Momentum into 2025 SILVER SPRING, Md., Nov. 14, 2024 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia” or the “Company”...

Elutia Announces New Peer Reviewed Publication Highlighting the Robustness of EluPro™, Company’s Antibiotic-Eluting BioEnvelope for Implantable Devices

EluPro eradicated bacteria commonly associated with cardiac implant-related infections in an established preclinical infection model SILVER SPRING, Md., Sept. 18, 2024 (GLOBE NEWSWIRE...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.635	-15.5446756426	4.085	4.151	3.385	19392	3.70099112	CS
4	-0.87	-20.1388888889	4.32	4.84	3.3	44567	4.24862126	CS
12	-0.25	-6.75675675676	3.7	5.12	2.78	41320	3.97554705	CS
26	-0.95	-21.5909090909	4.4	5.12	2.28	46811	3.93105944	CS
52	0.87	33.7209302326	2.58	5.24	2.28	41974	3.79197933	CS
156	2.26	189.915966387	1.19	5.24	1.1	120594	2.17863734	CS
260	2.26	189.915966387	1.19	5.24	1.1	120594	2.17863734	CS

ELUT - Frequently Asked Questions (FAQ)

What is the current Elutia share price?

The current share price of Elutia is US$ 3.45

How many Elutia shares are in issue?

Elutia has 34,562,098 shares in issue

What is the market cap of Elutia?

The market capitalisation of Elutia is USD 117.51M

What is the 1 year trading range for Elutia share price?

Elutia has traded in the range of US$ 2.28 to US$ 5.24 during the past year

What is the PE ratio of Elutia?

The price to earnings ratio of Elutia is -3.12

What is the cash to sales ratio of Elutia?

The cash to sales ratio of Elutia is 4.75

What is the reporting currency for Elutia?

Elutia reports financial results in USD

What is the latest annual turnover for Elutia?

The latest annual turnover of Elutia is USD 24.75M

What is the latest annual profit for Elutia?

The latest annual profit of Elutia is USD -37.66M

What is the registered address of Elutia?

The registered address for Elutia is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808

What is the Elutia website address?

The website address for Elutia is www.elutia.com

Which industry sector does Elutia operate in?

Elutia operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
FCUVFocus Universal Inc	US$ 0.9499 (174.93%)	260.93M
NITON2OFF Inc	US$ 2.6306 (145.85%)	358.28M
CRNCCerence Inc	US$ 19.33 (143.76%)	161.8M
KITTNauticus Robotics Inc	US$ 3.8249 (140.56%)	104.8M
ACONAclarion Inc	US$ 0.2984 (110.14%)	305.64M
HWHHWH International Inc	US$ 0.4621 (-28.80%)	7.43M
SMSTDefiance Daily Target 2x Short MSTR ETF	US$ 5.69 (-26.30%)	24.77M
RAINRain Enhancement Technologies Holdco Inc	US$ 5.59 (-23.42%)	161.15k
PTLEPTL Ltd	US$ 9.35 (-23.30%)	1.04M
NXUNXU Inc	US$ 0.725868 (-22.78%)	7.59M
NITON2OFF Inc	US$ 2.6306 (145.85%)	358.28M
TGLTreasure Global Inc	US$ 0.382 (101.58%)	337.5M
ACONAclarion Inc	US$ 0.2984 (110.14%)	305.64M
FCUVFocus Universal Inc	US$ 0.9499 (174.93%)	260.93M
NVDANVIDIA Corporation	US$ 144.47 (4.45%)	230.01M